Your browser doesn't support javascript.
Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients.
Maillard, Alexis; Redjoul, Rabah; Klemencie, Marion; Labussière Wallet, Hélène; Le Bourgeois, Amandine; D'Aveni, Maud; Huynh, Anne; Berceanu, Ana; Marchand, Tony; Chantepie, Sylvain; Botella Garcia, Carmen; Loschi, Michael; Joris, Magalie; Castilla-Llorente, Cristina; Thiebaut-Bertrand, Anne; François, Sylvie; Leclerc, Mathieu; Chevallier, Patrice; Nguyen, Stephanie.
  • Maillard A; Department of Clinical Hematology, Hôpitaux Universitaires Pitié Salpêtrière, Paris, France.
  • Redjoul R; Department of Clinical Hematology, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Henri Mondor, Créteil, France.
  • Klemencie M; Department of Clinical Hematology, Angers University Hospital, Angers, France.
  • Labussière Wallet H; Department of Clinical Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
  • Le Bourgeois A; Department of Clinical Hematology, Nantes University Hospital, Nantes, France.
  • D'Aveni M; Department of Hematology, Nancy Hospital, Nancy, France.
  • Huynh A; Department of Hematology, Institut Universitaire du Cancer Toulouse-Oncopole, Service de greffe de cellules souches hematopoïétiques, Toulouse, France.
  • Berceanu A; Department of Clinical Hematology, Besançon University Hospital, Besançon, France.
  • Marchand T; Department of Clinical Hematology, Centre Hospitalier Universitaire (CHU) de Rennes, Rennes, France.
  • Chantepie S; Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire de Caen, Caen.
  • Botella Garcia C; Department of Hematology and Cell Therapy, CHU de Bordeaux, Bordeaux, France.
  • Loschi M; Department of Hematology, CHU de Nice, Université Cote d'Azur, Nice, France.
  • Joris M; Department of Hematology, CHU Amiens, Amiens, France.
  • Castilla-Llorente C; Institut de Cancérologie Gustave Roussy, Villejuif, France.
  • Thiebaut-Bertrand A; Department of Clinical Hematology, CHU de Grenoble, Grenoble, France; and.
  • François S; Department of Clinical Hematology, Angers University Hospital, Angers, France.
  • Leclerc M; Department of Clinical Hematology, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Henri Mondor, Créteil, France.
  • Chevallier P; Department of Clinical Hematology, Nantes University Hospital, Nantes, France.
  • Nguyen S; Department of Clinical Hematology, Hôpitaux Universitaires Pitié Salpêtrière, Paris, France.
Blood ; 139(1): 134-137, 2022 01 06.
Article in English | MEDLINE | ID: covidwho-1533237
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / SARS-CoV-2 / COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 / Antibodies, Viral Type of study: Observational study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Blood Year: 2022 Document Type: Article Affiliation country: Blood.2021014232

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / SARS-CoV-2 / COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 / Antibodies, Viral Type of study: Observational study Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Blood Year: 2022 Document Type: Article Affiliation country: Blood.2021014232